Following recent coverage on patent protection rulings in India, Life Raft Group Executive Director, Norman Scherzer comments on what this might mean for cancer patients worldwide.
See Norman’s comments on patent protection in the video below:
“We agree that there is a major problem with regard to patient access, the question is access to what? Is it access to the drug that we had yesterday, to which many patients have developed resistance; or is it access to the drugs that we need tomorrow to keep patients alive.”
Watch the full video about patent protection on our YouTube page. Share your thoughts on this issue in the comment section below!
